The Cedars-Sinai Board of Governors Regenerative Medicine Institute is creating a resource laboratory to help advance stem cell-based technologies throughout Cedars-Sinai and across California.
The Wake Forest Institute for Regenerative Medicine (WFIRM) is honored to announce its selection for a pioneering cancer research project that will take place aboard the International Space Station (ISS).
With newly awarded funding from the National Science Foundation, researchers at the University of California, Irvine and the Keck School of Medicine of USC will seek to revolutionize the treatment of neurological diseases through intelligent biocomputing. The four-year, $2 million grant is part of NSF’s Emerging Frontiers in Research and Innovation program, which funds cutting-edge science pushing the boundaries of human knowledge.
Tempo Therapeutics, Inc. ("Tempo"), a leader in tissue engineering and regenerative medicine, has announced the dosing of the first patients in the MOSAIC Trial, a clinical trial for TT101, the company’s lead candidate for tissue regeneration using its proprietary MAP technology.
Researchers unveiled a novel therapy for diabetic wound healing. This research highlights the use of exosomal miR-4645-5p from hypoxic bone marrow mesenchymal stem cells (BMSCs) to significantly enhance wound healing by promoting keratinocyte autophagy.
One of the key goals of medical science is to speed up the healing of tissue injuries in a way that would not enable the forming of less functional scar tissue in the affected areas.
Surgeons and investigators from the Cedars-Sinai Orthopaedic Department will lead sessions featuring a range of orthopedic research at the 70th Annual Meeting of the Orthopaedic Research Society (ORS), Feb. 2-6, 2024, in Long Beach, Calif.
Scientists from Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago and Northwestern University succeeded in regenerating fully functional urinary bladder tissue in a long-term study utilizing a non-human primate model.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today the recipients of the 2023 ARVO Foundation Collaborative Research Fellowship: Marianna Hollaender, MD; Rodrigo Riedel, PhD; Paula Tenconi, PhD.
The Wake Forest Institute for Regenerative Medicine, part of Wake Forest University School of Medicine, has been selected to lead the Armed Forces Institute of Regenerative Medicine (AFIRM) Consortium.
With the rise in machine learning applications and artificial intelligence, it's no wonder that more and more scientists and researchers are turning to supercomputers. Supercomputers are commonly used for making predictions with advanced modeling and simulations. This can be applied to climate research, weather forecasting, genomic sequencing, space exploration, aviation engineering and more.
The Wake Forest Institute for Regenerative Medicine (WFIRM) has received a $6 million grant from the National Institute for Diabetes, Digestive and Kidney Diseases, part of the National Institutes of Health.
Scientists have created tiny moving biological robots from human tracheal cells that can encourage the growth of neurons across artificial ‘wounds’ in the lab. Using patients’ own cells could permit growth of Anthrobots that assist healing and regeneration in the future with no need for immune suppression
Our bodies are transversed by millions of nerve fibres that transmit information. This allows us to do things like control muscles and perceive sensory impressions. Peripheral nerves, like those in our arms and legs, are often damaged by acute injuries, for example, in accidents. As a result, those affected suffer from loss of muscle strength and sensory problems such as numbness. Peripheral nerves do have a strong regenerative potential, but complete recovery of nerve function is still rare for reasons that are not yet fully understood.
Anthony Atala, MD, FACS, a distinguished pediatric urologist from Winston-Salem, North Carolina, has been named the new Chair of the American College of Surgeons (ACS) Board of Regents. The announcement of his election to a one-year term came following the ACS Clinical Congress 2023 in Boston, Massachusetts.